DAY 17: THE LUNGS
Scleroderma Awareness Month
Raynaud's, Autoimmune Rare Disease
DAY 17: THE LUNGS
As highlighted in the diagram,
lung involvement in scleroderma patients can be a life threatening
complication, if not diagnosed and managed early on in the disease process.
Lung involvement, compared to
other organ involvement, currently, carries the highest threat to life for a
scleroderma patient, having overtaken kidney involvement.
Improved treatments and understanding have improved the long term outlook for the patient with kidney involvement.
Day 15 Scleroderma Awareness Month focussed on the kidney.
Improved treatments and understanding have improved the long term outlook for the patient with kidney involvement.
Day 15 Scleroderma Awareness Month focussed on the kidney.
One of the main diagnostic
tests carried out to confirm a scleroderma diagnosis, is a lung function test.
Day 5 Scleroderma Awareness Month: Diagnostic tests where I discuss the tests in more detail.
Day 5 Scleroderma Awareness Month: Diagnostic tests where I discuss the tests in more detail.
Huge thanks to Sarah Jatto, Facebook
‘Me and Sclero’, for sharing her experience of taking a lung
function test.
The diagram at the top of this
post shows an X-ray, whereby fibrosis to the left lung can be seen, identified
by the extra cloudy part to the base of the lung, as indicated.
Thankfully, the UK patient, Alex, who kindly shared her image for awareness purposes, is able to just about manage her symptoms without the use of an oxygen cylinder.
Thankfully, the UK patient, Alex, who kindly shared her image for awareness purposes, is able to just about manage her symptoms without the use of an oxygen cylinder.
In the event that treatments
are not effective and irreversible damage has been caused, a lung transplant is
a possible final option.
I wrote about the Swiss patient Alice, who underwent a double lung transplant in 2012, and was running a marathon, two years later.
I wrote about the Swiss patient Alice, who underwent a double lung transplant in 2012, and was running a marathon, two years later.
Recently, Nepalese patient
Prasha underwent a double lung transplant in New York and is making amazing
progress with her return to wellbeing. Please follow Prasha’s facebook page
‘Hope for Prasha – New Lungs’ and twitter @hopeforprasha
As highlighted within the
second paragraph above, lung fibrosis / pulmonary hypertension
complications in the scleroderma patient, are currently, the biggest
contributor to a life threatening situation.
To view the UK Scleroderma
Study best practice guidelines, Click here
2017 Update on Prasha: She is
most certainly a scleroderma medical miracle. She is infinitely grateful to her
donor for her new lungs and is currently undergoing a rigorous rehabilitation
programme.
I will be forever in awe with
the inner strength and tenacity which the superhuman lady, Prasha, has shown
throughout her recovery process. She is now able to walk about, is at home with
her family, but, her symptom management remains more than a full time job, for
her.
I very much look forward to
meeting Prasha, as well as Alice, at a global scleroderma meeting at some point
in the future.
An edited version of this article was published here, in my Column with Scleroderma News.
June 2016.
To read my articles:
Rare Disease Day 2018, Research - Taking Part in Clinical Trials, Click here
March Autoimmune Disease Awareness Month 2018, Click here
Global patient video, Click here
If we only had more RESEARCH investment for
Scleroderma, Raynaud's, Autoimmune Rare Disease, Click here
The Pandora’s Box of the rare autoimmune disease
Scleroderma, Raynaud's and Cancer, Click here
World Scleroderma Day 29th June 2016,
Click here
RARE DISEASE DAY:
Rare Disease Day 2018 – Research, Taking
Part in Clinical Trials. Scleroderma, Raynaud's, Autoimmune Rare Disease, Click here
2016 Rare Disease Day Patient Voice
2016 Rare Disease Day Patient Voice
Rare
Disease Day is a fantastic opportunity for the entire rare disease
community to shine a spotlight on their reality, combining as one unified
voice. Where, at least one commonality presides –
Medical
Research provides the brightest light
for the illumination of the rare disease
patients’ plight.
I
highlighted other areas of medical research interest within Week 3 of my Patient Profiles Campaign for Scleroderma Awareness Month 2017.
VIDEO
VIDEO
Although
rare disease patients are few in number, eg. 2.5 million scleroderma patients
worldwide, (the World Scleroderma Foundation), the commonalities and golden
hallmark for each rare disease patient are the same:
Early Diagnosis
Expert Specialist Centres
Access to Innovative Medicines
Where MEDICAL RESEARCH investment
is VITAL.
Research
is the key. Abstracts from 2016 World Congress, Click here
The Family Day at the Scleroderma Unit, The Royal
Free Hospital is taking place on the 19th May 2018. Browse the
program, here
This year, I am celebrating 20 years of being a
patient at this world leading expert specialist research centre.
Sept 2017 |
I am eternally grateful to the global scleroderma
trail blazers Dame Prof Black and Prof Chris Denton, whose commitment and
dedication to unlocking the scleroderma enigma, is nothing other than,
superhuman.
I am truly humbled and inspired by their work
ethic. I am wholly appreciative for Prof Denton’s continued medical expertise
and support, especially during my barrister qualifying years, 1997 -
2004.
1st March 2004, I qualified as a self
employed practising barrister. Further to having been told in 1997, by my
diagnosing doctor, that I was looking at a 15month prognosis.
I very much hope to utilise my professional skills
and qualifications along with my patient experience, to help achieve the
#SclerodermaFreeWorld dream, hoping to improve understanding and best practice,
in the meantime.
For latest updates follow:
Facebook Page:
Twitter: @SclerodermaRF @RaynaudsRf
Google Plus: RaynaudsSclerodermaAwarenessGlobalPatients
#SclerodermaFreeWorld
#RaynaudsFreeWorld
#ADAM #Scleroderma
#Raynauds
#RareDisease
Living the dream, scleroderma style.
Please DONATE to help
fund medical research at The Scleroderma Unit,The Royal Free Hospital, London.
100% of your monies will be used for medical
research purposes only. Thank You.
#HOPE
Last Update: April 2018
No comments:
Post a Comment